Magnetic pulses to the brain emerge as low-cost lifeline for depression

A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be ...
MassDevice

Abbott: Study shows neuromod systems greatly reduce pain-related healthcare visits

Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
Pharmabiz

Five-year data shows Abbott neuromodulation systems reduce healthcare visits related to pain and deliver sustained relief

Abbott Park, Illinois Tuesday, January 27, 2026, 13:00 Hrs [IST] ...
Medical Device Network on MSN

Boston Scientific touts long-term data of SCS therapy

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Science Daily

Brain waves could help paralyzed patients move again

People with spinal cord injuries often lose movement even though their brains still send the right signals. Researchers ...

Abbott Laboratories (NYSE:ABT) Q4 2025 earnings call transcript

Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript January 22, 2026 Abbott Laboratories reports earnings inline ...
sharewise

Will Robust Adult Nutrition Business Performance Fuel ABT's Q4 Earnings?

Abbott Laboratories ABT is slated to report fourth-quarter 2025 results on Jan. 22, before the opening bell. The company ...

PainTEQ Announces Appointment of Lalit Venkatesan, PhD as Senior Vice President of Clinical Research

TAMPA, Fla., Jan. 13, 2026 /PRNewswire/ -- PainTEQ, a medical device company dedicated to advancing minimally invasive solutions for sacroiliac (SI) joint dysfunction, today announced the appointment ...
wexnermedical.osu

Brian Dalm, MD

I’m a neurosurgeon specializing in pain and functional neurosurgical disorders. I received my medical training at Loyola University and completed my neurosurgery residency and functional neurosurgery ...
MarketWatch

First-of-its-Kind Study Shows Visibility into Real-Time Spinal Cord Stimulation Utilization and Supports a New Standard of Long-Term Device Management

The MarketWatch News Department was not involved in the creation of this content. Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use ...
Morningstar

First-of-its-Kind Study Shows Visibility into Real-Time Spinal Cord Stimulation Utilization and Supports a New Standard of Long-Term Device Management

Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use and lower explant rates LAKE OSWEGO, Ore., Jan. 5, 2026 /PRNewswire/ -- A new ...